Duane Cantrell
CEO @ Fulcrum Global Capital
Kansas City, United States
Duane Cantrell is a Series A investor at Fulcrum Global Capital in Kansas City focused on Biotechnology and AgTech. Duane brings extensive senior executive corporate domestic and international experience to Fulcrum Global Capital, LLC with recognized accomplishments in leadership and strategic positioning.Duane brought his expertise in leading other organizations through transformational change to the Kansas Bioscience Authority (KBA) in 2012 as its presidentand CEO where he led the organization to attract and grow the bioscience sector as an economic growth engine for the state of Kansas. His extensive background in growing companies in tough, competitive environments served the mission of the KBA and the entrepreneurial companies in its portfolio of investments.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Duane Cantrell invests in
Stages Duane Cantrell invests in
Countries Duane Cantrell invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- AgTech 1 (50%)
- Medical 1 (50%)
- Health Care 1 (50%)
Stage
- Series A 1 (50%)
- Venture - Series Unknown 1 (50%)
Country
- Ireland 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Talam Biotech
|
MicroGen Biotech uses Nature's microbes to reduce toxins in crops while increasing crop yields and reducing pollutants in arable soil. Our vision is to feed the world with safe foods produced sustainably. | Venture - Series Unknown / Jun 09, 2022 | |
Vytelle
|
Vytelle is a company with a deeper purpose and revolutionary technology that helps to advance bovine, deer and buffalo genetics faster by redefining reproduction. | $13.2M / Series A / Sep 28, 2021 |
Co-Investors
About Fulcrum Global Capital
Fulcrum Global Capital invests in companies disrupting agriculture and animal health.
Fulcrum Global Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Kevin Lockett
Partner and CFO
|
|||
|
Duane Cantrell
CEO
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Duane Cantrell invest in?
Duane Cantrell invests primarily in Biotechnology, AgTech and Medical startups, most often at Series A and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Duane Cantrell last invest?
The most recent investment recorded for Duane Cantrell closed in Jun 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
